Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | STOXX® Europe 600 Health Care |
| Investment focus | Equity, Europe, Health Care |
| Fund size | CHF 61 m |
| Total expense ratio | 0.30% p.a. |
| Replication | Synthetic (Unfunded swap) |
| Legal structure | ETF |
| Investment approach | Long-only |
| Sustainability | No |
| Fund currency | EUR |
| Currency risk | Currency unhedged |
| Volatility 1 year (in CHF) | 15.87% |
| Inception/ Listing Date | 2 July 2020 |
| Distribution policy | Distributing |
| Distribution frequency | Annually |
| Fund domicile | Luxembourg |
| Fund Provider | Amundi ETF |
| Fund Structure | Company With Variable Capital (SICAV) |
| UCITS compliance | Yes |
| Administrator | SOCIETE GENERALE LUXEMBOURG |
| Investment Advisor | |
| Custodian Bank | SGSS - Paris |
| Revision Company | PWC |
| Fiscal Year End | 31 December |
| Swiss representative | Société Générale, Paris, Zweigniederlassung Zürich |
| Swiss paying agent | Société Générale, Paris, Zweigniederlassung Zürich |
| Germany | 30% tax rebate |
| Switzerland | ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | UK Reporting |
| Italy | 26.0% |
| Indextype | Total return index |
| Swap counterparty | BNP Paribas |
| Collateral manager | |
| Securities lending | No |
| Securities lending counterparty |
| Roche Holding AG | 15.58% |
| Novartis AG | 15.08% |
| AstraZeneca PLC | 13.01% |
| Novo Nordisk A/S | 7.58% |
| GSK Plc | 5.29% |
| Sanofi | 5.21% |
| argenx | 3.28% |
| EssilorLuxottica SA | 3.03% |
| Bayer AG | 2.91% |
| Lonza Group AG | 2.60% |
| Broker | Rating | Execution fee | Account fee | |
|---|---|---|---|---|
| | 0.00 CHF | 0.00 CHF | View offer* | |
| | 0.00 CHF | 0.00 CHF | View offer* |
| YTD | -2.16% |
| 1 month | +0.13% |
| 3 months | -4.19% |
| 6 months | -1.56% |
| 1 year | +0.14% |
| 3 years | +6.07% |
| 5 years | +3.35% |
| Since inception (MAX) | +13.76% |
| 2025 | +5.28% |
| 2024 | +5.96% |
| 2023 | +1.71% |
| 2022 | -10.66% |
| Current dividend yield | 1.34% |
| Dividends (last 12 months) | CHF 2.35 |
| Period | Dividend in CHF | Dividend yield in % |
|---|---|---|
| 1 Year | CHF 2.35 | 1.34% |
| 2025 | CHF 2.35 | 1.36% |
| 2024 | CHF 3.00 | 1.82% |
| 2023 | CHF 2.75 | 1.67% |
| 2022 | CHF 3.82 | 2.02% |
| Volatility 1 year | 15.87% |
| Volatility 3 years | 16.47% |
| Volatility 5 years | 16.30% |
| Return per risk 1 year | 0.01 |
| Return per risk 3 years | 0.12 |
| Return per risk 5 years | 0.04 |
| Maximum drawdown 1 year | -12.44% |
| Maximum drawdown 3 years | -27.46% |
| Maximum drawdown 5 years | -27.46% |
| Maximum drawdown since inception | -27.46% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | EHLT | - - | - - | - |
| XETRA | EUR | EHLT | EHLT GY CNAVSXDR | EHLT.DE EHLTEURINAV=SOLA | Societe Generale Corporate and Investment Banking |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| Amundi STOXX Europe 600 Healthcare UCITS ETF Acc | 830 | 0.30% p.a. | Accumulating | Swap-based |
| iShares STOXX Europe 600 Health Care UCITS ETF (DE) | 691 | 0.46% p.a. | Distributing | Full replication |